Atherosclerosis in Behçet's syndrome

Clinical and Experimental Rheumatology

Volumn 25, Issue 4 SUPPL. 45, 2007, Pages

  Seyahi, Emire ^a   Yazici, Hasan ^a,b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Arterial stiffness; Atherosclerosis; Beh et's syndrome; Cardiovascular disease; Carotid artery plaques; Coronary artery disease; Intima media thickness

Indexed keywords

ANKYLOSING SPONDYLITIS; ARTERY CALCIFICATION; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTOIMMUNE DISEASE; BEHCET DISEASE; CEREBROVASCULAR DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE ACTIVITY; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HUMAN; LIPID PEROXIDATION; MORTALITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; ANTIBODY PRODUCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAROTID ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; DISEASE ASSOCIATION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE PERFUSION; HISTOPATHOLOGY; LIPID BLOOD LEVEL; SYSTEMIC VASCULITIS;

ADULT; BEHCET SYNDROME; CORONARY ARTERY DISEASE; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED;

LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; TRIACYLGLYCEROL;

EID: 35448983997     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (64)

1. VAN DOORNUM S, MCCOLL G, WICKS IP: Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002; 46: 862-73.
2. SHOENFELD Y, GERLI R, DORIA A et al.: Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005; 112: 3337-47.
3. MANZI S, MEILAHN EN, RAIRIE JE et al.: Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study. Am J Epidemiol 1997; 145: 408-15.
4. SHERER Y, SHOENFELD Y: Atherosclerosis. Ann Rheum Dis 2002; 61: 97-9.
5. VAN DER WAL AC, BECKER AE, VAN DER LOOS CM, DAS PK: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44.
6. VAN DER WAL AC, DAS PK, TIGGES AJ, BECKER AE: Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol 1992; 141: 1427-33.
7. LIBBY P, RIDKER PM: InflammaRion and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 2004; 116 (Suppl. 6A): 9S-16S.
8. PASCERI V, YEH ET: A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 1999; 100: 2124-6.
9. SEYAHI E, UGURLU S, CUMALI R et al.: Atherosclerosis in Takayasu arteritis. Ann Rheum Dis 2006; 65: 1202-7.
10. DE LEEUW K, SANDERS JS, STEGEMAN C, SMIT A, KALLENBERG CG, BIJL M: Accelerated atherosclerosis in patients with Wegener's granulomatosis. Ann Rheum Dis 2005; 64: 753-9.
11. SHERER Y, PAGNOUX C, CHIRONI G et al.: Carotid artery intima-media thickness, heat-shock proteins and oxidized LDL autoantibodies in systemic necrotizing vasculitis. Ann Rheum Dis 2007; 66 (Suppl. II): 76.
12. KURAL-SEYAHI E, FRESKO I, SEYAHI N et al.: The long-term mortality and morbidity of Behçet syndrome: A 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003; 82: 60-76.
13. KOC Y, GULLU I, AKPEK G et al.: Vascular involvement in Behçet's disease. J Rheumatol 1992; 19: 402-10.
14. CHAJEK T, FAINARU M: Behçet's disease. Report of 41 cases and a review of the literature. Medicine (Baltimore) 1975; 54: 179-96.
15. MISHIMA Y, ISHIKAWA K, UENO A: Arterial involvement in Behçet's disease. Jpn J Surg 1973; 3: 52-60.
16. SHIMIZU T, EHRLICH GE, INABA G, HAYASHI K: Behçet disease (Behçet syndrome). Semin Arthritis Rheum 1979; 8: 223-60.
17. KAKLAMANI VG, VAIOPOULOS G, KAKLAMANIS PG: Behçet's Disease. Semin Arthritis Rheum 1998; 27: 197-217.
18. KASEDA S, KOIWAYA Y, TAJIMI T et al.: Huge false aneurysm due to rupture of the right coronary artery in Behçet's syndrome. Am Heart J 1982; 103(4 Pt 1): 569-71.
19. SIEPMANN M, KIRCH W: Coronary anomaly in Behçet's syndrome. Rheumatol Int 1997; 17: 39-42.
20. IPEK G, OMEROGLU SN, MANSUROGLU D, KIRALI K, UZUN K, SISMANOGLU M: Coronary artery bypass grafting in a 26-year-old man with total occlusion of the left main coronary artery related to Behçet disease. J Thorac Cardiovasc Surg 2001; 122: 1247-9.
21. LAKHANPAL S, TANI K, LIE JT, KATOH K, ISHIGATSUBO Y, OHOKUBO T: Pathologic features of Behçet's syndrome: A review of Japanese autopsy registry data. Hum Pathol 1985; 16: 790-5.
22. BUDOFF MJ, GEORGIOU D, BRODY A et al.: Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: A multicenter study. Circulation 1996; 93: 898-904.
23. SEYAHI E, MEMISOGLU E, HAMURYUDAN V et al.: Coronary atherosclerosis in Behçet's syndrome: A pilot study using electron-beam computed tomography. Rheumatology (Oxford). 2004; 43: 1448-50.
24. KARCI C, SEYAHI E, YAZICI H, YURDAKUL S, HAMURYUDAN V: Comorbidities in Behçet Syndrome. Clin Exp Rheumatol 2006; 24 (Suppl. 42): S43.
25. UROWITZ MB, BOOKMAN AA, KOEHLER BE, GORDON DA, SMYTHE HA, OGRYZLO MA: The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976; 60: 221-5.
26. WOLFE F, MITCHELL DM, SIBLEY JT et al.: The mortality of rheumatoid arthritis. Arthritis Rheum 1994; 37: 481-94.
27. PROTOGEROU A, LEKAKIS J, STAMATELOPOULOS K et al.: Arterial wall characteristics in patients with Adamantiades-Behçet's disease. Adv Exp Med Biol 2003; 528: 399-404.
28. ALAN S, ULGEN MS, AKDENIZ S, ALAN B, TOPRAK N: Intima-media thickness and arterial distensibility in Behçet's disease. Angiology 2004; 55: 413-9.
29. OFLAZ H, MERCANOGLU F, KARAMAN O et al.: Impaired endothelium-dependent flow-mediated dilation in Behçet's disease: more prominent endothelial dysfunction in patients with vascular involvement. Int J Clin Pract 2005; 59: 777-81.
30. KESER G, AKSU K, TAMSEL S et al.: Increased thickness of the carotid artery intima-media assessed by ultrasonography in Behçet's disease. Clin Exp Rheumatol 2005; 23 (Suppl. 38): S71-6.
31. OZTURK MA, OKTAR SO, UNVERDI S et al.: Morphologic evidence of subclinical atherosclerosis obtained by carotid ultrasonography in patients with Behçet's disease. Rheumatol Int 2006; 26: 867-72.
32. CALISKAN M, GULLU H, YILMAZ S et al.: Cardiovascular prognostic value of vascular involvement in Behçet's disease. Int J Cardiol 2007 Apr 2; [Epub ahead of print].
33. SEYAHI E, UGURLU S, CUMALI R et al.: Atherosclerosis in Behçet's syndrome. Arthritis Rheum 2005; 52: S647.
34. DEL PORTO F, LAGANA B, LAI S et al.: Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. Rheumatology (Oxford) 2007; 46: 1111-5.
35. VAUDO G, BOCCI EB, SHOENFELD Y et al.: Precocious intima-media thickening in patients with primary Sjögren's syndrome. Arthritis Rheum 2005; 52: 3890-7.
36. BELCARO G, NICOLAIDES AN, LAURORA G et al.: Ultrasound morphology classification of the arterial wall and cardiovascular events in a 6-year follow-up study. Arterioscler Thromb Vasc Biol 1996; 16: 851-6.
37. EBRAHIM S, PAPACOSTA O, WHINCUP P et al.: Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: The British Regional Heart Study. Stroke 1999; 30: 841-50.
38. ADAMS MR, NAKAGOMI A, KEECH A et al.: Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation 1995; 92: 2127-34.
39. DEL SOL AI, MOONS KG, HOLLANDER M et al.: Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke 2001; 32: 1532-8.
40. OZKAN M, EMEL O, OZDEMIR M et al.: M-mode, 2-D and Doppler echocardiographic study in 65 patients with Behçet's syndrome. Eur Heart J 1992; 13: 638-41.
41. TUNC SE, DOGAN A, GEDIKLI O, ARSLAN C, SAHIN M: Assessment of aortic stiffness and ventricular diastolic functions in patients with Behçet's disease. Rheumatol Int 2005; 25: 447-51.
42. BOZKURT A, AKPINAR O, UZUN S, AKMAN A, ARSLAN D, BIRAND A: Echocardiographic findings in patients with Behçet's disease. Am J Cardiol 2006; 97: 710-5.
43. CALGUNERI M, ERBAS B, KES S, KARAASLAN Y: Alterations in left ventricular function in patients with Behçet's disease using radionuclide ventriculography and Doppler echocardiography. Cardiology 1993; 82: 309-16.
44. KOMSUOGLU B, GOLDELI O, KULAN K et al.: Doppler evaluation of left ventricular diastolic tilling in Behçet's disease. Int J Cardiol 1994; 47: 145-50.
45. GEMICI K, BARAN I, GULLULU S, KAZAZOGLU AR, CORDAN J, OZER Z: Evaluation of diastolic dysfunction and repolarization dispersion in Behçet's disease. Int J Cardiol 2000; 73: 143-8.
46. IKONOMIDIS I, LEKAKIS J, STAMATELOPOULOS K, MARKOMIHELAKIS N, KAKLAMANIS PG, MAVRIKAKIS M: Aortic elastic properties and left ventricular diastolic function in patients with Adamantiades-Behçet's disease. J Am Coll Cardiol 2004; 43: 1075-81.
47. GULLU IH, BENEKLI M, MUDERRISOGLU H et al.: Silent myocardial ischemia in Behçet's disease. J Rheumatol 1996; 23: 323-7.
48. TURKOLMEZ S, GOKCORA N, ALKAN M, GORER MA: Evaluation of myocardial perfusion in patients with Behçet's disease. Ann Nucl Med 2005; 19: 201-6.
49. GULLU H, CALISKAN M, ERDOGAN D et al.: Patients with Behçet's disease carry a higher risk for microvascular involvement in active disease period. Ann Med 2007; 39: 154-9.
50. CHAMBERS JC, HASKARD DO, KOONER JS: Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol 2001; 37: 517-20.
51. OZDEMIR R, BARUTCU I, SEZGIN AT et al.: Vascular endothelial function and plasma homocysteine levels in Behçet's disease. Am J Cardiol 2004; 94: 522-5.
52. KAYIKCIOGLU M, AKSU K, HASDEMIR C et al.: Endothelial functions in Behçet's disease. Rheumatol Int 2006; 26: 304-8.
53. KURUM T, YILDIZ M, SOY M, OZBAY G, ALIMGIL L, TUZUN B: Arterial distensibility as determined by carotid-femoral pulse wave velocity in patients with Behçet's disease. Clin Rheumatol 2005; 24: 134-8. 52
54. FILER AD, GARDNER-MEDWlN JM, THAMBYRAJAH J et al.: Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa. Ann Rheum Dis 2003; 62: 162-7.
55. BACON PA: Endothelial cell dysfunction in systeNic vasculitis: new developments and therapeutic prospects. Curr Opin Rheumatol 2004; 17: 49-55.
56. RAZA K, CARRUTHERS DM, STEVENS R, FILER AD, TOWNEND JN, BACON PA; Infliximab leads to a rapid but transient improvement in endothelial function in patients with primary systemic vasculitis. Ann Rheum Dis 2006; 65: 946-8.
57. RAZA K, THAMBYRAJAH J, TOWNEND JN et al.: Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: Lessons for atherosclerotic disease? Circulation 2000; 102: 1470-2.
58. LEIBA M, SELIGSOHN U, SIDI Y et al.: Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease. Ann Rheum Dis 2004; 63: 1445-9.
59. OREM A, EFE H, DEGER O, CIMSIT G, UYDU HA, VANIZOR B: Relationship between lipid peroxidation and disease activity in patients with Behçet's disease. J Dermatol Sci 1997; 16: 11-6.
60. KARAKUCUK S, BASKOL G, ONER AO, BASKOL M, MIRZA E, USTDAL M: Serum paraoxonase activity is decreased in the active stage of Behçet's disease. Br J Ophthalmol 2004; 88: 1256-8.
61. OREM A, CIMSIT G, DEGER O, VANIZOR B, KARAHAN SC: Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behçet's disease. Dermatology 1999; 198: 243-6.
62. OREM A, YANDI YE, VANIZOR B, CIMSIT G, UYDU HA, MALKOC M: The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease. Clin Biochem 2002; 35: 217-24.
63. YAZICI H: The place of Behçet's syndrome among the autoimmune diseases. Int Rev Immunol 1997; 14:1-10.
64. SARI I, OKAN T, AKAR S et al.: Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford) 2006; 45: 283-6.